An effective type I interferon (IFN-α/β) response is critical for the control of many viral infections. Using an oncolytic strain of vesicular stomatitis virus, we have examined the cross-talk between virus-induced apoptosis and initiation of innate immune response. The intrinsic apoptotic cascade, specifically the Bax-Bcl-2-Caspase-9 cascade, was revealed as the primary pathway of VSV-induced apoptosis. Cell death was significantly reduced in BaxBak −/− murine embryonic fibroblasts (MEFs) and in human A549 epithelial cells treated with siRNA against Bax.
Introduction
Apoptosis represents an evolutionary conserved pathway that is important for development, cellular homeostasis, and cellular defense against microbial and viral pathogens (Opferman and Korsmeyer, 2003) . The mitochondria represent a central crossroad, where pro-and anti-apoptotic signals are integrated (Green and Kroemer, 2004) . Following an apoptotic trigger, mitochondria undergo loss of inner mitochondrial membrane potential and subsequent mitochondrial membrane permeabilization (MMP) and release of death-promoting factors such as cytochrome c, SMAC/Diablo, and endonuclease G (Wang, 2001 ). The mitochondrial-mediated apoptotic cascade is tightly regulated by members of the Bcl-2 family (Cory et al., 2003; Ruffolo and Shore, 2003) . Antiapoptotic members of the Bcl-2 family, such as Bcl-xL and Bcl-2, prevent Bax and Bak oligomerization, thereby interfering with cytochrome c release (Gross et al., 1999; Scorrano and Korsmeyer, 2003) . Among the pro-apoptotic members, small BH3-only proteins such as Bid, Bad, Noxa, and Puma may initiate the death signal, whereas the multidomain proteins Bax and/or Bak are required for commitment to cell death via the mitochondrial pathway . In viable cells, Bax and Bak exist as inactive monomers in the cytosol or loosely attached to membranes; in response to a variety of death stimuli, Bax/Bak insert into the outer mitochondrial membrane as homooligomerized multimers (Griffiths et al., 1999; Gross et al., 1998) . Consequently, the release of cytochrome c from the mitochondria activates the Apaf-1/caspase-9 apoptosome and downstream effector caspases (Li et al., 1997) , leading to irreversible cell death. Loss of both Bax and Bak therefore results in profound resistance to many apoptotic stimuli, including death receptor signaling and genotoxic agents Degenhardt et al., 2002) .
To inhibit apoptosis, many viruses encode proteins that function directly at the mitochondrial level (Boya et al., 2001) . In fact, apoptosis is an innate defense mechanism to intracellular pathogen infection. In the course of evolution, many viruses have acquired the ability to encode products that interfere with the mitochondrial-dependent apoptotic pathway for their own benefit (Everett and McFadden, 2001; Hardwick and Bellows, 2003) . For example, M11L, a myxoma-virus encoded antiapoptotic protein, blocks apoptosis by preventing Bax conformational change (Su et al., 2006) . Similarly, E1B 19K from adenovirus interacts with and blocks Bax and Bak oligomerization to inhibit mitochondrial induced cell death (Perez and White, 2000; Sundararajan et al., 2001) . Vaccinia virus, a member of the poxvirus family, encodes an anti-apoptotic protein, F1L that interacts with Bak and inhibits its activation (Wasilenko et al., 2005 ). Karposi's sarcoma-associated herpesvirus (KSHV) encodes a viral K7 protein that contains a portion of a baculovirus inhibitor of apoptosis repeat domain and putative BH2 domain (Wang et al., 2002) . Following KSHV infection, K7 localizes to the mitochondria and interacts with activated caspase 3, Bcl-2, and calcium-modulating cyclopilin ligand, resulting in the regulation of cellular calcium levels and inhibition of apoptosis (Feng et al., 2002) . In the context of VSV infection, it was recently demonstrated that M protein contains a mitochondrial targeting motif and inserts into the mitochondrial membrane (Lichty et al., 2006) .
A major consequence of virus infection is the induction of the type I interferons (IFNs), a family of cytokines essential for the development of innate and adaptive defense (Hiscott et al., 2006b; Honda and Taniguchi, 2006; Nakhaei et al., 2006; Stetson and Medzhitov, 2006) . Activation of the ubiquitous transcription factor interferon regulatory factor 3 (IRF-3) is critical for the initiation of the IFN antiviral response. The IKK-related kinases TBK1 and IKKε function as essential components of the virus-activated complex that phosphorylate and activate IRF-3, as well as the closely related IRF-7 (Fitzgerald et al., 2003; Sharma et al., 2003) . A unique cytoplasmic signaling pathway utilizes the retinoic acid inducible gene I (RIG-I) to recognize a variety of RNA viruses and trigger the innate antiviral response (Yoneyama et al., 2004) . A link between RIG-I dependent innate immune response and the mitochondria was recently established. Several groups identified a novel CARD domain-containing adapter molecule -mitochondrial antiviral response (MAVS)/ interferon-β stimulator 1 (IPS-1)/virus induced signaling adapter (VISA)/CARD-domain containing IFN inducer (Cardif) -involved in RIG-I-dependent signaling to the IKKα/β complex and to TBK1/IKKε (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005) . MAVS/IPS-1/ VISA/Cardif functions as a critical adapter molecule between early detection of virus infection by RIG-I and downstream signaling events leading to IFN production (Seth et al., 2005; Xu et al., 2005) . In addition, Seth et al. showed that the knockdown of MAVS using siRNA resulted in the partial cleavage of the apoptosis marker Poly (ADP-ribose) polymerase (PARP), thus suggesting a role for MAVS/IPS-1/ VISA/Cardif in the inhibition of apoptosis. Thus, it seems likely that events at the RIG-I-MAVS-IKKε mitochondrial complex may influence both the host antiviral response and virus-induced apoptosis (Hiscott et al., 2006a) . The successful propagation of virus is therefore intertwined with its ability to overcome apoptosis, as well as the host innate and adaptive immune response.
VSV, the prototypic member of the family Rhabdoviridae, is an enveloped virus with a single negative strand genomic RNA. Intriguingly, VSV is exquisitely sensitive to IFN antiviral response, thus making this virus unable to replicate efficiently in normal cells in vitro and in vivo (Balachandran and Barber, 2000; Ebert et al., 2003; Fernandez et al., 2002; Lichty et al., 2004; Stojdl et al., 2000; Stojdl et al., 2003) . However the oncolytic capacity of VSV resides with its selective ability to replicate in a variety of cancer cells in vitro and to target and destroy tumor cells in immunocompetent animal models in vivo (Balachandran and Barber, 2000; Ebert et al., 2003; Fernandez et al., 2002; Lichty et al., 2004; Stojdl et al., 2003) . For example, VSV infection selectively killed a large panel of human tumor cell lines including 80% of the NCI 60 tumor cell bank, cleared bone marrow of leukemic AML cells and effectively arrested metastatic spread of CT26 lung metastases in immunocompetent animals (Fernandez et al., 2002; Stojdl et al., 2000 Stojdl et al., , 2003 .
VSV induces mitochondrial dependent apoptosis in a caspase-9/Apaf-1 dependent manner, in part through the viral matrix M protein, which shuts off host mRNA export from the nucleus via interaction with the Nup98 and Rae1 nuclear pore complex proteins (Balachandran et al., 2001; Enninga et al., 2002; Faria et al., 2005; Fontoura et al., 2005; Gadaleta et al., 2005; Kopecky and Lyles, 2001; Von Kobbe et al., 2000) . The export block leads to depolarization of the mitochondrial membrane as well as release of cytochrome c and AIF (Gadaleta et al., 2005; Modjtahedi et al., 2006) . Stojdl et al. characterized natural IFN-inducing VSV variants (AV1 and AV2) with single point mutations in the M protein that decrease the ability of the M protein to block host mRNA nuclear export, in part due to impaired interactions with Nup98 and Rae1 Stojdl et al., 2003; Von Kobbe et al., 2000) . As a consequence, AV1 and AV2 have an improved therapeutic index as oncolytic agents compared to wild type VSV (Gaddy and Lyles, 2007; Stojdl et al., 2003) .
The current study was therefore undertaken to understand further the molecular pathways regulating VSV-induced apoptosis and to establish a link between MMP and triggering of IFN antiviral response. This report demonstrates that Bax/Bak-dependent mitochondrial apoptotic pathway represents a major component required for the initiation of VSV-induced cell death and enhancement of the IFN antiviral response.
Results

Requirements for VSV-induced apoptosis
In many cell types including numerous tumor cells, there is coordination and cross talk between the extrinsic and intrinsic apoptotic cascades in the initiation of apoptosis (Danial and Korsmeyer, 2004; Opferman and Korsmeyer, 2003) . Thus, we first sought to investigate the involvement of the extrinsic or intrinsic cell death pathways in VSV-induced apoptosis (Fig.  1A) . VSV replication and the loss of mitochondrial transmembrane potential (Δψm) occurred to similar levels in wildtype (WT), FADD negative or caspase-8 negative Jurkat cells, demonstrating that the extrinsic apoptotic pathway was not the main pathway for VSV-induced cell death or proteolytic activation of caspase 3 regardless of strain of VSV virus used (VSV-AV1 or HR) (Fig. 1B and Supplementary Figs. 1 and 2 ). Since the BH3-only proapoptotic protein BID links the extrinsic pathway to the mitochondria (Luo et al., 1998) , mouse embryonic fibroblasts (MEF) deficient in BID (Bid −/− ) were used to further assess the link between the extrinsic and the mitochondrial-dependent intrinsic pathway in the initiation of VSV-mediated apoptosis. No differences in the kinetics of cell death induction or mitochondrial depolarization were observed in Bid −/− MEFs compared to WT MEFs (Supplementary Fig. 3) .
These results implied that the intrinsic apoptotic pathway was involved in VSV-induced cell death. Therefore caspase-9 −/− MEFs or caspase-2/9 −/− double knockout MEFs were used to determine whether blocking the intrinsic pathway would affect VSV-induced apoptosis. Compared with WT MEFs, caspase-9 −/− or caspase-2/9 −/− MEFs appeared morphologically resistant to VSV-induced apoptosis at 16 h post-infection ( Fig. 2A ). Recombinant VSV expressing GFP was used to examine cell death in individual cells infected with VSV. Microscopically, WT MEFs infected with VSV-GFP showed an apoptotic phenotype ( Fig. 2B ), whereas no cell death was observed in caspase-9 −/− or caspase-2/9 −/− MEFs infected with VSV-GFP. Quantification of virus replication by plaque assay revealed that the yield of infectious virus in caspase-9 −/− and caspase-2/9 −/− MEFs were comparable to WT MEFs (Fig. 2C ). Immunoblot analysis of lysates from WT, caspase-9 −/− , caspase-2/9 −/− MEFs demonstrated that VSV replication was not inhibited by blocking the intrinsic apoptotic pathway (Fig. 2D, upper panel) . In contrast, a delay in the accumulation of active caspase-3 was detected in caspase-9 −/− cells (Fig. 2D, middle panel) . In WT MEFs, accumulation of the active caspase-3 form (p19) was detected at 6 h, whereas, in caspase-9 −/− MEFs, caspase-3 activation was delayed to 16 h post-infection. Under similar conditions, activation of caspase-3 was almost undetectable in caspase-2/9 −/− MEFs (Fig. 2D , right panel). Taken together, these results specify a central role for intrinsic apoptotic pathway in VSV-mediated cell death.
Bax activity is required for VSV-induced apoptotic signaling
Mitochondrial apoptotic signaling was next examined in BaxBak −/− MEFs . As with caspase-9
MEFs, the Bax/Bak deficiencies dramatically reduced the ability of VSV to induce microscopic apoptosis, even at MOI 100 ( Fig. 3A) . In parallel, BaxBak −/− MEFs were examined for DNA content and MMP activity; the absence of Bax/Bak inhibited DNA condensation and fragmentation (Fig. 3B) , and blocked the ability of VSV to induce rapid MMP loss ( Fig. 3C ) as compared to WT MEFs. Surprisingly, the level of VSV replication was substantially increased in BaxBak −/− as compared to WT MEFs; yet, the proteolytic caspase-3 cleavage was delayed in these cells (12 vs 6 h) (Fig. 3D) . A plaque assay was used to distinguish whether the increase in VSV proteins was due to the accumulation of viral proteins in surviving cells or to an enhancement of viral replication; a 10-fold increase in virus yield was detected in BaxBak −/− MEFs 16 h post-VSV infection (4.5 × 10 5 pfu/ml), compared to the yield in WT MEFs (4.2 × 10 4 pfu/ml) ( Fig. 3E ). Similar results were observed in BaxBak −/− and WT MEFs infected with VSV-HR (Supplementary Fig. 4) . A caspase-3 fluorometric activity assay demonstrated an 8-fold increase in caspase-3 activity in WT MEFs infected with VSV-AV1 compared to BaxBak −/− MEFs; similarly, a 4-fold increase in caspase-3 activity was observed in WT MEFs infected with VSV-HR compared to BaxBak −/− MEFs (Fig. 3F) . Finally, the relative requirement for Bax and/or Bak pro-apoptotic proteins was determined. As illustrated in Fig. 3G , Bax but not Bak deficiency inhibited VSV-induced cell death, thus providing a link between Bax but not Bak proapoptotic protein and the ability of VSV to initiate apoptosis.
Impaired antiviral responsive gene induction in the absence of BaxBak
Given the robust replication of VSV detected in MEFs lacking Bax/Bak, we next sought to determine whether BaxBak deficiency would modulate the host response to virus infection. RNA from WT and BaxBak −/− MEFs was examined by microarray analysis using a murine cDNA array containing 15,000 unique genes. A reduction in the expression of several key IFN-inducible genes was detected at 12 h post infection in the BaxBak −/− MEFs (Fig. 4A) . Importantly, attenuation in the expression of IFNα genes, particularly Ifnα4, Ifnα5, Ifnα6, Ifnα7, and Ifnα11 was detected in BaxBak deficient but not in WT MEFs (Fig. 4B) . The impairment of IFN gene activation in the absence of Bax/Bak was confirmed at the mRNA level by RT-PCR; as shown in Fig. 4C , RT-PCR analysis revealed that the expression of antiviral genes was decreased 2-13 fold in BaxBak −/− MEFs (Fig. 4C , lower panel and 4D) compared to that of WT MEFs (Fig. 4C , upper panel and 4D). These results indicate that the high level of VSV replication in BaxBak −/− MEFs was a consequence of the decreased production of type I IFN in these cells.
Diminished IRF-3 phosphorylation in VSV-infected BaxBak-deficient MEFs
Since virus-induced IRF-3 activation by phosphorylation is necessary for IFN gene induction (Lin et al., 1998; Yoneyama et al., 1998) , IRF-3 activation in BaxBak −/− MEFs was next investigated. Upon phosphorylation at the carboxyl terminus, the migration of IRF-3 on SDS-PAGE is reduced, resulting in the detection of slowly migrating phosphorylated forms. Following VSV infection, weak induction of forms III and IV was detected in BaxBak −/− MEFs, whereas in WT MEFs a strong shift of IRF-3 to forms III and IV was observed by 8 h post-infection (Fig. 5A) . Nuclear extracts prepared from infected MEFs (Fig. 5B) of mitochondrial-dependent cell death, regardless of viral replication. Next, the contribution of Bax and Bak proteins was determined; EMSA analysis revealed that the formation of the specific IRF-3-DNA complex was reduced in the absence of Bax (Fig. 5F ) but not Bak (Fig. 5E ). In contrast, EMSA analysis demonstrated strong NF-κB DNA binding activity in both the WT and BaxBak −/− MEFs, indicating that the inhibition of IRF-3 binding activity was specific and not a generalized effect in BaxBak −/− MEFs (Fig. 5G) .
Diminished IRF-3 phosphorylation in VSV-infected Bax knock-down A549 cells
Next, we sought to determine if the siRNA knock-down of Bax in human A549 epithelial cells would affect IRF3 phosphorylation following VSV infection. A549 cells were treated with specific siRNA targeting Bax and 48 h later infected with VSV-AV1. Bax siRNA knock-down in A549 cells resulted in diminished IRF3 phosphorylation following virus infection and resulted in the enhancement of VSV replication (Fig. 6A ). In addition, apoptotic cell death was decreased in Bax knock-down A549 cells infected with VSV-AV1 (Fig. 6B) .
Overexpression of Bax confers IRF-3 binding activity
Because the absence of Bax resulted in diminished IRF-3 phosphorylation and DNA binding following VSV infection, we asked whether Bax overexpression would induce IRF-3 binding activity in the absence of viral infection. Overexpression of murine Bax protein induced cell death (Fig.  7A) , and MMP loss (Fig. 7B ) at 48 h post-transfection. Concomitant with the induction of cell death, IRF-3-DNA binding complex was detected by EMSA in extracts from mBax transfected but not in control lysates (Fig. 7C) , indicating that Bax-mediated MMP and apoptosis contributes to enhance the induction of IRF-3 activity.
Discussion
The emergence of VSV as a potential therapeutic anticancer agent has stimulated interest in the relationship between the mechanisms of VSV induced apoptosis and the initiation of the host antiviral response. Within this context, the present study has addressed the role of cross-talk between apoptosis and antiviral pathways in the full development of the innate host response to virus infection (Hiscott et al., 2006a ). Our results demonstrate that regardless of the VSV strain -wildtype Indiana or the naturally attenuated AV1 -both viruses require the mitochondrial-dependent pathway of apoptosis to induce programmed cell death, irrespective of the initial triggering of the intrinsic or extrinsic apoptotic pathway. Furthermore, the proapoptotic protein Bax is an early activator of the mitochondrial depolarization triggered by VSV replication. Inhibition of VSV-mediated MMP in BaxBak −/− MEFs resulted in the impaired development of the host antiviral response. These data establish a link between Baxdependent MMP and full development of the host antiviral response.
The mitochondrial pathway is regulated by both proapoptotic and antiapoptotic members of the Bcl-2 family in which Bax and Bak confer an essential gateway for the activation of caspases in this pathway (Ruiz-Vela et al., 2005) . Previous studies suggested that Bax and Bak were functionally redundant with respect to their role in apoptosis. Cytochrome c release occurs in Bax −/− Bak +/+ and Bax +/+ Bak −/− MEFs but not in Bax/Bak −/− MEFs during stress-induced cell death (Cheng et al., 2003; Wei et al., 2001 ). Hence, deletion of both Bax and Bak is required to confer resistance to apoptosis induced by different stimuli (Lindsten et al., 2000; Wei et al., 2001 ). Based on a recent model -termed the "switched rheostat" model -the ratio of anti-to proapoptotic proteins constitutes a balance that set the threshold of susceptibility to apoptosis for the intrinsic pathway (Bagci et al., 2006) . Activation and oligomerization of Bax or/and Bak results in permeabilization of the mitochondrial outer membrane to initiate cytochrome c release and other cofactors involved in the efficient activation of effector caspases (Annis et al., 2005; Antonsson, 2001; Korsmeyer et al., 2000) . Based on this model, antiapoptotic Bcl-2 protects cells principally by inhibiting mitochondrial permeabilization through binding and sequestering "BH3-only" activator molecules Wei et al., 2001 ).
An earlier report demonstrated that VSV initiated early MMP leading to cell death (Gadaleta et al., 2005) . Caspase 9 activation correlated with the release of both cytochrome c and AIF from the mitochondrial intermembrane space. Gaddy et al. also showed that VSV AV1 induced apoptosis via the extrinsic pathway, distinct from cell death induced through the intrinsic pathway by wild type VSV (Gaddy and Lyles, 2005) . The inability of the M mutated AV1 virus to inhibit host gene expression resulted in the activation of all three major initiator caspases -caspase-8, caspase-9, and caspse-12, as well as the executioner caspase-3 (Gaddy and Lyles, 2005) . Furthermore, treatment with the caspase-8 inhibitor of cells infected with VSV-AV1 prevented the activation of caspase-9 but not caspase-12, indicating that caspase-8 activates caspase-9 (Gaddy and Lyles, 2005) . This cross-talk suggests a mechanism by which VSV-AV1 initially signals through the death receptor pathway, but ultimately both WT and VSV-AV1 require the intrinsic mitochondrial pathway to initiate cell death. Recently, an alternative adaptor protein Daxx was identified as an important component of apoptosis induced by VSV-AV1 and Daxx appears to be more important than FADD for apoptosis induced by VSV-AV1 (Gaddy and Lyles, 2007) . Furthermore, dominant-negative mutants of Fas and PKR inhibited AV1-induced apoptosis, and Daxx possessed novel functions in the host response to virus infection by mediating virus-induced apoptosis (Gaddy and Lyles, 2007) .
Our results indicate that Bax represents the convergence point of VSV-mediated cell death, regardless of the VSV strain: 1) both VSV strains were able to infect, replicate, and kill cells defective in the extrinsic apoptotic pathway with similar efficacy; 2) mitochondrial membrane potential loss was triggered by both strains with similar kinetics, regardless of the absence of extrinsic pathway; 3) cell death induced by both strains was comparable in Bid −/− MEFs; and 4) both viruses failed to induce caspase-3 cleavage in BaxBak −/− MEFs. The inability of VSV to induce cell death in BaxBak −/− MEFs was not dependent on the amount of virus, since an MOI of 100 was still unable to induce cell death, demonstrating a prerequisite of this intrinsic pathway to trigger efficient apoptosis in infected cells. Enhanced virus replication and release from infected cells in BaxBak −/− MEFs (Figs. 3D and E) demonstrate that disruption of the intrinsic death pathway negatively affected the full establishment of the antiviral response. In the absence of Bax/Bak pathway, IRF3 phosphorylation, nuclear translocation, and DNA binding were all diminished (Fig. 5) . Knock-down of Bax in A549 cell line resulted in decreased IRF3 phosphorylation, as well as the enhancement of viral replication (Fig. 6) . Indeed, microarray analysis confirmed a decreased expression of many immune response genes in A mitochondrial-targeting domain was recently identified in VSV M protein that mediates the insertion of M into the outer mitochondrial membrane (Lichty et al., 2006) . It is thus conceivable that the multi-functional M protein not only inhibits host gene expression but also enhances mitochondrial-dependent apoptosis and MMP by interacting with proapoptotic proteins from the mitochondrial intermembrane space. An understanding of the role of mitochondria in viral pathophysiology may have important therapeutic implications for the development of oncolytic viruses; however, a role for MMP in the regulation of the innate response to virus infection was unexpected. Viruses have evolved diverse mechanisms to modulate apoptosis by inhibiting MMP at the beginning of the virus life cycle or stimulating MMP at the end of infectious life cycle. Viral control of apoptosis of infected cells at the mitochondrial level may also represent a defined strategy to dampen the antiviral response. For example, the hepatitis C virus NS3-4A protease complex specifically targets MAVS/ IPS-1/VISA/Cardif for cleavage as part of its immune evasion strategy (Cheng et al., 2006; Lin et al., 2006; Meylan et al., 2005) . Furthermore, the hepatitis C virus NS3-4A protease disrupts an IFN signaling complex composed of MAVS, IKKepsilon and potentially other proteins at the mitochondrial membrane (Lin et al., 2006 ).
An important determinant in the decision between antiviral response or apoptosis may be the recruitment of IKKε to the mitochondria. Recently, Drosophila IKK-related kinase (DmIKKε) was shown to function as a regulator of caspase activation through direct phosphorylation of Drosophila inhibitor of apoptosis (DIAP1) (Kuranaga et al., 2006) . IAPs are endogenous caspase inhibitors that block caspase-3, -7 and -9 activity and block the downstream portion of the apoptosis pathway (Salvesen and Duckett, 2002; Vaux and Silke, 2005; Zong et al., 2001) . Importantly, the human homologue IKKε phosphorylated XIAP and facilitated its degradation (Kuranaga et al., 2006) , implying that IKKε MEFs were infected with VSV-AV1 strain at an MOI of 1 pfu/cell. Samples were collected 12 h post infection. IRF-3 DNA binding activity was analyzed by EMSA in WCE as in C. Specific antibody against IRF-3 or cold probe was used to identify specific IRF-3-DNA complexes. Protein-DNA complexes corresponding to IRF-3 and IRF-2 are indicated. G: NF-κB DNA binding activity in WCE was analyzed using kB1 as probe. Specific antibody against NF-κB or cold probe was used to identify specific NF-κB complexes. Protein-DNA complexes corresponding to NF-κB are indicated. Results are representative of three separate experiments.
recruitment via MAVS may coordinate the induction of an apoptotic response through XIAP phosphorylation and turnover. Based on the results of the present study, Bax/Bak dependent mitochondrial depolarization and the intrinsic death pathway enhance the full development of an effective antiviral response (Hiscott et al., 2006a) . Ongoing studies are investigating the relationship between the mitochondrial apoptotic pathway, RIG-I signaling events and the initiation of the IFN antiviral response.
Materials and methods
Cell culture
Wild-type MEFS, caspase-9 −/− , caspase-2/9 −/− , Bak −/− , Bax −/− , BaxBak −/− , Bid −/− , HEK 293T, and Vero African green monkey kidney cells were cultured in Dulbecco's modified Eagle's medium (Wisent INC). Wild-type, caspase-9 −/− , caspase-2/9 −/− , Bak −/− , Bax −/− , and BaxBak −/− cells were derived from C57BL/6 mouse genetic background and immortalized with SV40 T antigen. Caspase-9
−/− and caspase-2/9 −/− cells were provided by Dr. Strasser (Marsden et al., 2004) . Bak −/− , Bax −/− , BaxBak −/− and Bid −/− cells were provided by Dr. Korsmeyer ). The Jurkat caspase-8 −/− and FADD −/− cell lines were provided by Dr. J Blenis (Juo et al., 1998 (Juo et al., , 1999 
Immunoblotting
Total lysates were extracted and Western blot analysis was performed as previously described (Sharif-Askari et al., 2001) . Briefly, cells were washed with PBS and lysed in lysis buffer (0.05% NP40, 0.1% glycerol, 30 mM NaF, 40 mM β-glycerophosphate, 10 mM Na 3 VO 4 , 10 ng/ml of protease inhibitors (leupeptin, aprotinin, pepstatin)). Protein concentration was determined with Bio-Rad protein assay reagent (BioRad), and 20 μg of protein was then resolved using 12-14% SDS-PAGE and transferred to nitrocellulose membrane (Hybond C Super; Amersham, Oakville, Canada). Blots were blocked for 1 h at 25°C in 5% non-fat dried milk in PBST (PBS + 0.5% Tween-20). The following antibodies were used: rabbit anti-VSV (1:5000), anti-Rho-GDI (BD Pharmigen, 1:5000), anti-procaspase 3 (Upstate, 1:2000), anti-Bax (Santa Cruz, 1:1000) anti-cleaved caspase 3 (Cell Signaling, 1:2000) , or mouse anti-β actin (Chemicon, 1:1000). For IRF-3 analysis, 40 μg of protein was loaded on 7.5% SDS-PAGE and immunoblot analysis was performed using rabbit anti-IRF-3 (Zymed, 1 μg/ml). The immunocomplexes were detected with horseradish peroxidase-conjugated secondary antibodies and enhanced chemiluminescence (ECL, Amersham Biosciences).
Virus production, quantification and infection
Wild-type VSV (Indiana serotype), AV1 VSV, and rVSV-GFP were propagated in Vero cells as described previously (Stojdl et al., 2003) . Viruses were obtained from cell-free supernatants and titrated on Vero cells by standard plaque assay. Virus yields were expressed as plaque forming unit (PFU) of released virus per milliliter. Cells were mock-infected or infected with VSV virus as previously described (TenOever et al., 2004) . For rVSV-GFP, virus replication was analyzed using inverted microscopy equipped with UV lamp (Zeiss, Axiovert 25).
Microarray analysis
cDNA preparation and microarray analyses were performed at the LDI Microarray Facility. Total RNA was extracted with the Qiagen RNeasy RNA isolation kit (Qiagen), and amplified with the MessageAmp aRNA amplification kit (Ambion). A second round of amplification was performed with the SuperArray TrueLabeling-AMP linear amplification kit to incorporate biotin-16-UTP (SuperArray). RNA quality was assessed with the 2100 Bioanalyzer (Agilent Technologies). The Oligo GEArray mouse interferon α, β response microarray (SuperArray, OMM-016) was used for probe hybridization. For each condition, triplicate arrays were hybridized independently. Numerical data analyses were performed with the GEArray Analyzer Software (SuperArray). Briefly, raw signal intensities were corrected for background by subtracting minimum value, normalized to the median, and the mean adjusted to value of 100. A gene table was generated with the average of all replicates per gene. Ratio of expression levels in WT versus BaxBak −/− MEFs was generated for all time points and genes differentiating the classes with ratios above 2 were selected as significant. The Gene table of significant values was imported into GeneTraffic Software (Iobion) to permit the simultaneous evaluation of multiple experiments and visualization of coordinate patterns of gene regulation.
RT-PCR
Whole RNA from treated cells was extracted using Trizol (Invitrogen) according to the manufacturer's instructions. RNA purity was analyzed using an Agilent 2100 Bioanalyzer with the RNA 6000 NanoLabChip (Agilent Technologies). RT-PCR was performed using 1 μg of RNA resuspended in RNase-free ddH 2 O and Oligo dT primer (Clontech) according to the manufacturer's conditions. Reverse transcription was performed using Superscript II (Invitrogen) at 42°C for 1 h. Following the reverse transcription reactions, cDNA samples were brought to 100-μl final volumes of which 5 μl was used as template for each independent PCR with Taq polymerase (Amersham). The primer sequences used in this study for PCR were:RANTES, 5′-ATATGGCTCGGACACCACTC-3′ and 5′-TGGGAGTAGGGGATTACTGG-3′; IP-10, 5′-AAG-TGCTGCCGTCATTTTCT-3′ and 5′-CACTGGGTAAAGGG-GAGTGA-3′, IFN-β, 5′-CACAGCCCTCTCCATCAACT-3′ and 5′-TCCCACGTCAATCTTTCCTC-3′, IL-6, 5′-ATGAAG-TTCCTCTCTGCAAGAGACT-3′ and 5′-TCCAGTTTG-GTAGCATCCATC-3′, IL-15, 5′-CATTTTGGGCTGTGTCA-GTG-3′ and 5′-TCTCCTCCAGCTCCTCACAT-3′, TNF-α, 5′-AGTCCGGGCAGGTCTACTTT-3′ and 5′-CTCCCTTT-GCAGAACTCAGG-3′, GAPDH, 5′-AGGAGCGAGAC-CCCACTAAC-3′ and 5′-GTGGTTCACACCCATCACAA-3′. All primers were designed using Primer 3 software (Rozen and Skaletsky, 2000) . PCR fragments were amplified at an annealing temperature of 55°C for 35 cycles. Products were run on a 1% agarose gel and revealed through use of a Typhoon 9400 phosphoimager (Amersham).
Nuclear protein purification
Cells were washed with PBS and cytosolic fraction was removed by incubating the cells with 100-300 ul TKM buffer (10 mM Tris (pH 7.6), 10 mM KCl, 5 mM MgCl 2 , 0.2% NP40, 0.5 mM PMSF, 1 mM DTT, 10 ug/ml Leupeptin) for 15 min on ice, followed by 5 min of low speed spinning. Palettes were then washed with cold TKM buffer and lysed for 5 min on ice with nuclear lysis buffer (0.05% NP40, 0.1% glycerol, 30 mM NaF, 40 mM β-glycerophosphate, 10 mM Na 3 VO 4 , 10 ug/ml of protease inhibitors). Following 3 times of freeze and thaw, nuclear extracts were collected after 30 min spinning at 13,000 rpm. Protein concentration was determined with BioRad protein assay reagent (BioRad), and 100 μg of protein was then resolved using 7.5% SDS-PAGE.
Electrophoretic mobility shift assay (EMSA)
Whole-cell extracts prepared from MEFs as detailed above were subjected to EMSA using γ-32 P-labeled probes. The binding reaction was carried out in a 20-μl final volume in binding buffer containing 20 mM HEPES (pH 7.9), 5% glycerol, 0.1 M KCl, 0.2 mM EDTA (pH 8), 0.2 mM EGTA (pH 8), and 1 μg of poly(dI-dC) using 20 μg protein extract from the indicated cells. The following oligonucleotide probes were used: IRF-3, 5′-GATCGGGAAAGGGAAACCGA-AACTGAAGCC-3′ κB1, 5′-CTCTGCAAAGCGAAGTCCC-CTTCGCAC-3′. Protein/DNA complexes were resolved on 5% polyacrylamide-0.5× Tris-borate-EDTA gels and exposed to Biomax XR film (Kodak) overnight at − 80°C. Supershift analysis was performed for 15 min at room temperature using 1 μg of anti-IRF-3, or anti-p65 (Santa Cruz Biotechnology).
Measurement of apoptosis
Apoptotic cells were quantified by Annexin V/propidium iodide (PI) double staining for detection of the apoptotic plasma membrane (phosphatidylserine translocation) (54). The percentage of nuclei with subdiploid DNA content (sub-G1 DNA) was determined by PI staining as described (Ren et al., 2004) . The Mitochondrial transmembrane potential (Δψm) was examined by staining cells with JC-1 reagent (Molecular Probes), according to the manufacturer's protocol.
RNAi
Bax siRNA for the inhibition of Bax expression in human cells was purchased from Santa Cruz (sc-29212), along with fluorescein conjugated control siRNA (sc-36869). Briefly, siRNA oligos at a final concentration of 250 pmol were transfected into A549 cells using lipofectamine 2000 reagent (Invitrogen). This transfection procedure was repeated on the second day to increase RNAi efficiency. On the third day, cells were infected with VSV-AV1 at an MOI of 1 pfu/cell and cells were harvested by trypsinization at the indicated time points.
Measurement of caspase-3 activity
DEVDase assay was performed following the manufacturer's instructions (Biomol, Plymouth, PA). Briefly, cells were infected with VSV-AV1 or VSV-HR for 12 and 24 h, harvested by trypsinization, and then lysed with lysis buffer provided in the kit (supplemented with 0.1% Triton X-100). The assay is based on the cleavage of the substrate DEVD bonded to the chromophore p-nitroanilide (pNA), which is measured by reading the absorbance (at 405-nm wavelength) of the samples (maintained at 37°C) at 15-min increments for 90 min. The protein content was determined by Bradford assay. The rate of cleavage of pNA pmol/min/μg of protein allows for calculation of specific activity. 
